Manic-depressive disorder
Aripiprazole has been currently approved, by US Food and Drug Administration to treat bipolar disorder as well as schizophrenia, to treat manic-depressive disorder and schizophrenia.A new study suggests that it importantly and dose-dependently increases the sedative effects of alcohol and, to a lesser degree, lessens the ecstatic sort of effects of alcohol.

The following results have been published in the April issue of Alcoholism: Clinical & Experimental Research.

(more…)